At Double Helix, we transform the most promising startups and scale-ups into industry leaders through our venture capital and SPV funds.
We are dedicated to driving innovation in health tech and life sciences, supporting early-stage companies ready to scale and late-stage growth businesses. Our focus is on identifying and empowering high-potential ventures in these critical sectors.
With a tailored investment approach, we provide not only the financial resources needed to innovate and grow but also the strategic guidance that only a team of entrepreneurs with deep roots in health tech and life sciences can offer. We help companies scale effectively, maximizing their market impact.
Target Sectors:
Diagnostics, Preventive Health, and Precision Medicine: From early detection to precision monitoring and risk stratification in both clinical and consumer contexts.
Health Data, Software, and AI Infrastructure: Solutions that deliver measurable clinical and economic value across the healthcare chain.
Life Sciences Tools, Automation, and Industrialization: Platforms that accelerate discovery, development, and large-scale manufacturing in biotech and pharma.
Longevity, Wellness, and Personalized Health: Evidence-based products and platforms that enhance health and performance throughout life.


Double Helix HealthTech

Org chart

Teams

Offices

Double Helix HealthTech

Org chart

Teams

Offices

Related companies